Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
IHE
36
HOLDINGS
17%
ALSO IN MEDX
MEDX
28
HOLDINGS
21%
ALSO IN IHE
SECTOR DRIFT (IHE minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.0% | 14.5% | 14.5% |
|
JOHNSON & JOHNSON | 24.5% | 4.9% | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 3.9% | 4.4% | 3.9% |
|
PFIZER INC | 4.2% | 3.5% | 3.5% |
|
MERCK & CO. INC. | 4.4% | 3.2% | 3.2% |
IHE Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 19.6% |
|
ELI LILLY & CO | 5.5% |
|
ROYALTY PHARMA PLC CLASS A | 4.6% |
|
VIATRIS, INC. | 4.5% |
|
ELANCO ANIMAL HEALTH, INC. | 4.3% |
|
ZOETIS INC | 3.8% |
 |
JAZZ PHARMACEUTICALS PLC | 3.6% |
|
CORCEPT THERAPEUTICS INC | 3.2% |
|
AXSOME THERAPEUTICS, INC. | 2.3% |
|
LIGAND PHARMACEUTICALS-CL B | 1.5% |
IHE Underweight Relative to MEDX
|
ABBVIE INC | -9.6% |
 |
NOVARTIS AG-ADR | -6.8% |
|
ALNYLAM PHARMACEUTICALS INC | -6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
|
IONIS PHARMACEUTICALS, INC. | -4.5% |
|
AMGEN INC | -3.7% |
|
ALKERMES PLC | -3.6% |
|
CRISPR THERAPEUTICS AG | -3.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% |
|
BIOGEN IDEC INC | -2.6% |